694 related articles for article (PubMed ID: 26446897)
1. Analytical methodology for metabolomics study of adherent mammalian cells using NMR, GC-MS and LC-HRMS.
Madji Hounoum B; Blasco H; Nadal-Desbarats L; Diémé B; Montigny F; Andres CR; Emond P; Mavel S
Anal Bioanal Chem; 2015 Nov; 407(29):8861-72. PubMed ID: 26446897
[TBL] [Abstract][Full Text] [Related]
2. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
3. Workflow methodology for rat brain metabolome exploration using NMR, LC-MS and GC-MS analytical platforms.
Diémé B; Lefèvre A; Nadal-Desbarats L; Galineau L; Madji Hounoum B; Montigny F; Blasco H; Andres CR; Emond P; Mavel S
J Pharm Biomed Anal; 2017 Aug; 142():270-278. PubMed ID: 28531831
[TBL] [Abstract][Full Text] [Related]
4. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue.
Naz S; García A; Barbas C
Anal Chem; 2013 Nov; 85(22):10941-8. PubMed ID: 24144172
[TBL] [Abstract][Full Text] [Related]
5. Joint GC-MS and LC-MS platforms for comprehensive plant metabolomics: repeatability and sample pre-treatment.
t'Kindt R; Morreel K; Deforce D; Boerjan W; Van Bocxlaer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3572-80. PubMed ID: 19762291
[TBL] [Abstract][Full Text] [Related]
6. A review of strategies for untargeted urinary metabolomic analysis using gas chromatography-mass spectrometry.
Khodadadi M; Pourfarzam M
Metabolomics; 2020 May; 16(6):66. PubMed ID: 32419109
[TBL] [Abstract][Full Text] [Related]
7. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
Emwas AH
Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
[TBL] [Abstract][Full Text] [Related]
8. Rat Fecal Metabolomics-Based Analysis.
Deda O; Gika HG; Theodoridis GA
Methods Mol Biol; 2018; 1738():149-157. PubMed ID: 29654588
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
Lopes AS; Cruz EC; Sussulini A; Klassen A
Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
[TBL] [Abstract][Full Text] [Related]
10. Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics.
Beltran A; Suarez M; Rodríguez MA; Vinaixa M; Samino S; Arola L; Correig X; Yanes O
Anal Chem; 2012 Jul; 84(14):5838-44. PubMed ID: 22697410
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
[TBL] [Abstract][Full Text] [Related]
12. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
[TBL] [Abstract][Full Text] [Related]
14. GC-MS, LC-MS(n), LC-high resolution-MS(n), and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high "Kanna" isolated from Sceletium tortuosum.
Meyer GM; Wink CS; Zapp J; Maurer HH
Anal Bioanal Chem; 2015 Jan; 407(3):761-78. PubMed ID: 25240931
[TBL] [Abstract][Full Text] [Related]
15. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.
Naz S; Moreira dos Santos DC; García A; Barbas C
Bioanalysis; 2014; 6(12):1657-77. PubMed ID: 25077626
[TBL] [Abstract][Full Text] [Related]
16. Postprandial metabolomics: A pilot mass spectrometry and NMR study of the human plasma metabolome in response to a challenge meal.
Karimpour M; Surowiec I; Wu J; Gouveia-Figueira S; Pinto R; Trygg J; Zivkovic AM; Nording ML
Anal Chim Acta; 2016 Feb; 908():121-31. PubMed ID: 26826694
[TBL] [Abstract][Full Text] [Related]
17. Sample preparation methods for LC-MS-based global aqueous metabolite profiling.
Beltran A; Samino S; Yanes O
Methods Mol Biol; 2014; 1198():75-80. PubMed ID: 25270923
[TBL] [Abstract][Full Text] [Related]
18. Extending metabolome coverage for untargeted metabolite profiling of adherent cultured hepatic cells.
García-Cañaveras JC; López S; Castell JV; Donato MT; Lahoz A
Anal Bioanal Chem; 2016 Feb; 408(4):1217-30. PubMed ID: 26769129
[TBL] [Abstract][Full Text] [Related]
19. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
